VolitionRx Limited announced that it has further strengthened its Scientific Advisory Board with the addition of Dr. Lee-Jen Wei, a professor of Biostatistics at Harvard University. Wei's main area of research is developing statistical methods for the design and analysis of clinical trials. His recent research is concentrated on revitalizing clinical trial methodology and utilizing biomarkers under the risk-benefit paradigm for personalized medicine. He has worked closely with the pharmaceutical industry and regulatory agencies to aid both the development and evaluation of new products.